# Madrigal Pharmaceuticals
 (stock symbol: MDGL) Logo in transparent PNG format

## Madrigal Pharmaceuticals
 Logo large

### Madrigal Pharmaceuticals
 Logo large Download PNG (5.12 KB)

![Madrigal Pharmaceuticals
 Logo large Download PNG (5.12 KB)](/img/orig/MDGL_BIG-f79131f5.png)

## Madrigal Pharmaceuticals
 Logo icon format

### Madrigal Pharmaceuticals
 Logo icon format Download PNG (1.36 KB)

![Madrigal Pharmaceuticals
 Logo icon format Download PNG (1.36 KB)](/img/orig/MDGL-c16abefa.png)

## About Madrigal Pharmaceuticals


Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ÃŸ agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

1. Website domain: madrigalpharma.com
2. Employees: 71
3. Marketcap: $5.65 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
